BOLT Lithotripsy RESTORE BTK Trial

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Peripheral Arterial DiseasePeripheral Vascular Disease
Interventions
DEVICE

Intravascular Lithotripsy

Enhancing percutaneous transluminal angioplasty by utilizing delivery of IVL to disrupt calcium in below the knee lesions prior to full balloon dilatation at low pressures

Trial Locations (4)

Unknown

Medical University of Graz, Graz

University Hospital of Split, Split

Klinikum Hochsauerland GmbH, Arnsberg

08661

Vilnius University Hospital Santaros clinics, Vilnius

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bolt Medical

INDUSTRY

NCT05535907 - BOLT Lithotripsy RESTORE BTK Trial | Biotech Hunter | Biotech Hunter